DGEM-Leitlinie Enterale Ernährung:Onkologie

J. Arends; G. Zürcher; R. Fietkau; E. Aulbert; B. Frick; M. Holm; M. Kneba; H. J. Mestrom; A. Zander

doi:10.1055/s-2003-36939

Aktuelle Ernährungsmedizin, Inhaltsverzeichnis

Aktuelle Ernährungsmedizin 2003; 28: 61-68
DOI: 10.1055/s-2003-36939

Onkologie

DGEM-Leitlinie Enterale Ernährung:
Onkologie

DGEM Guidelines Enteral Nutrition: OncologyJ. Arends¹ , G. Zürcher² , R. Fietkau³ , E. Aulbert⁴ , B. Frick⁵ , M. Holm⁶ , M. Kneba⁷ , H. J. Mestrom⁸ , A. Zander⁹

¹Klinik für Tumorbiologie an der Albert-Ludwigs Universität Freiburg
²Innere Medizin I - Hämatologie, Onkologie, Med. Universitätsklinik und Poliklinik, Freiburg
³Klinik und Poliklinik für Strahlentherapie, Universität Rostock
⁴Innere Abt. Ev. Waldkrankenhaus Spandau
⁵Apotheke des Universitätsklinikums Freiburg
⁶II. Med. Klinik, Univ.-Klinikum Mannheim
⁷II. Med. Klinik, Universität Kiel
⁸Klinik Bergisch-Land, Wuppertal
⁹Einrichtung für Knochenmarktransplantation, Universitätsklinik Hamburg-Eppendorf

Abstract

Schlüsselwörter

Sondenernährung - Onkologie - Mangelernährung - Kachexie - Komplikationen

Key words

Enteral nutrition - oncology - malnutrition - cachexia - complications

Volltext

Referenzen

Literatur

1 Pichard C, Kyle U G. Body composition measurements during wasting diseases. Clin Nutr Metab Care. 1998; 1 357-361
2 ASPEN Board of Directors, Clinical Guidelines Task Force . Specific guidelines for disease - adults: cancer. JPEN. 2002; 26 82SA-83SA
3 Blackburn G L, Bistrian B R, Maini B R, Schlamm H T, Smith M F. Nutritional and metabolic assessment of the hospitalized patient. JPEN. 1977; 1 11-22
4 Detsky A S, McLaughlin J R, Baker J P. et al . What is Subjective Global Assessment of Nutritional Status?. JPEN. 1987; 11 8-13
5 Dwyer J T. Dietary Assessment. In: Shils ME, Olson JA, Shike M (eds) Modern nutrition in health and disease. Philadelphia; Lea & Febiger 1994: 842-860
6 Hackl J M, Balogh D. Indikation zur künstlichen Ernährung - was ist gesichert?. Akt Ernährungsmed. 1997; 22 146-153
7 Arbeitsgemeinschaft für Klinische Ernährung .Empfehlungen für die parenterale und enterale Ernährungstherapie des Erwachsenen. 2000
8 Ollenschläger G, Konkol K, Mödder B. Indications for and results of nutritional therapy in cancer patients. Recent Results Cancer Res. 1988; 108 172-184
9 van Hoof P, Buill-Haasen M, Rouflart N, Soeters P B, von Meyenfeldt M F. Anorexia, malnutrition and food aversion with newly detected gastric or colorectal cancer. Clin Nutr. 1989; 8 151
10 DGE, ÖGE, SGE, SVE .Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main; Umschau Braus 2000
11 DeWys W D, Begg C, Lavin P T. et al . Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980; 69 491-497
12 Chute C G, Greenberg E R, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer. 1985; 56 2107-2111
13 Wigmore S J, Plester C E, Richardson R A, Fearon K CH. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer. 1997; 75 106-109
14 Andreyev H JN, Norman A R, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer. 1998; 34 503-509
15 Costa G, Donaldson S S. Current concepts in cancer. N Engl J Med. 1979; 300 1471-1473
16 McAnena O J, Daly J M. Impact of antitumor therapy on nutrition. Surg Clin North Am. 1986; 66 1213-1228
17 Knox L S, Crosby L O, Feurer I D, Buzby G P, Miller C L, Mullen J L. Energy expenditure in malnourished cancer patients. Ann Surg. 1983; 197 152-161
18 Dempsey D T, Feurer I D, Knox L S, Crosby L O, Buzby G P, Mullen J L. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer. 1984; 53 1265-1273
19 Dempsey D T, Knox L S, Mullen J L, Miller C L, Feurer I D, Buzby G P. Energy expenditure in malnourished patients with colorectal cancer. Arch Surg. 1986; 121 789-795
20 Moldawer L L, Copeland E M. Proinflammatory cytokines, nutritional support, and the cachexia syndrom. Cancer. 1997; 79 1828-1839
21 de Blaauw I, Deutz N EP, von Meyenfeldt M F. Metabolic changes in cancer cachexia - first of two parts. Clin Nutr. 1997; 16 169-176
22 de Blaauw I, Deutz N EP, von Meyenfeldt M F. Metabolic changes of cancer cachexia - second of two parts. Clin Nutr. 1997; 16 223-228
23 Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?. Cancer Res. 1999; 59 4493-4501
24 von Meyenfeldt M F. Nutritional support during treatment of biliopancreatic malignancy. Ann Oncol. 1999; 10 273-277
25 Fearon K CH, Barber M D, Falconer J S, McMillan D C, Ross J A, Preston T. Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg. 1999; 23 584-588
26 Fordy C, Glover C, Henderson D C, Summerbell C, Wharton R, Allen-Mersh T G. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. Br J Surg. 1999; 86 639-644
27 Simons J PFHA, Schols A M, Buurman W A, Wouters E F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci. 1999; 97 215-223
28 Espat N J, Moldawer L L, Copeland E M. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol. 1995; 58 77-82
29 Martin F, Santolaria F, Batista N. et al . Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine. 1999; 11 80-86
30 O'Gorman P, McMillan D C, McArdle C S. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer. 2000; 37 36-40
31 Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res. 1978; 38 4665-4670
32 Starnes H F, Warren R S, Brennan M F. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy. J Clin Invest. 1987; 80 1384-1390
33 Shaw J HF, Wolfe R R. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg. 1997; 205 368-376
34 Zuijdgeest-van Leeuwen S D, van den Berg J WO, Wattimena J LD. et al . Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism. 2000; 49 931-936
35 Körber J, Pricelius S, Heidrich M, Müller M J. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr. 1999; 53 740-745
36 Barber M D, McMillan D C, Preston T, Ross J A, Fearon K CH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci. 2000; 98 389-399
37 Legaspi A, Jeevanandam M, Starnes H F, Brennan M F. Whole body lipid and energy metabolism in the cancer patient. Metabolism. 1987; 36 958-963
38 Jeevanandam M, Horowitz G D, Lowry S F, Brennan M F. Cancer cachexia and protein metabolism. Lancet. 1984; 1 1424-1426
39 Williams A, Sun X, Fischer J F, Hasselgren P O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery. 1999; 126 744-750
40 Bossola M, Muscaritoli M, Costelli P. et al . Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regulatory Integrative Comp Physiol. 2001; 280 R1518-R1523
41 Tisdale M J. Protein loss in cancer cachexia. Science. 2000; 289 2293-2294
42 Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer I W. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer. 2001; 84 1599-1601
43 Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin's Disease. Cancer Res. 1971; 31 1801-1810
44 Swenerton K D, Legha S S, Smith T. et al . Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979; 39 1552-1562
45 van Eys J. Effect of nutritional status on response to therapy. Cancer Res. 1982; 42 747-753
46 Pedersen H, Hansen H S, Cederqvist C, Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand. 1982; 148 363-366
47 Fein R, Kelsen D P, Geller N, Bains M, McCormack P, Brennan M F. Adenocarcinoma of the esophagus and gastroesophageal junction. Cancer. 1985; 56 2512-2518
48 Coates R J, Clark W S, Eley J W, Greenberg R S, Huguley C M, Brown R L. Race, nutritional status and survival from breast cancer. J Natl Cancer Inst. 1990; 82 1684-1692
49 van Bokhorst-de van der Schueren M AE, van Leeuwen P AM, Kuik D J. et al . The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999; 86 519-527
50 Ollenschläger G, Thomas W, Konkol K, Diehl V, Roth E. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Invest. 1992; 22 546-553
51 Bruning P F, Egger R J, Gooskens A C. et al . Dietary intake, nutritional status and well-being of cancer patients: a prospective study. Eur J Cancer. 1985; 21 1449-1459
52 Padilla G V. Psychological aspects of nutrition and cancer. Surg Clin North Am. 1986; 66 1121-1135
53 Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlentherapie und Onkologie. 1998; 174 47-51
54 Ovesen L, Allingstrup L, Hannibal E, Mortensen E L, Hansen P. Effect of dietary counseling on food intake body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective randomized study. J Clin Oncol. 1993; 11 2043-2049
55 Edington J, Winter P D, Coles S J, Gale C R, Martyn C N. Outcomes of undernutrition in patients in the community with cancer or cardiovascular disease. Proc Nutr Soc. 1999; 58 655-661
56 Warren S. The immediate causes of death in cancer. Am J Med Sci. 1932; 184 610-615
57 Aslani A, Smith R C, Allen B J, Paviakis N, Levi J A. The predictive value of body protein for chemotherapy-induced toxicity. Cancer. 2000; 88 796-803
58 Anonymous . American Gastroenterological Association medical position statement: parenteral nutrition. Gastroenterology. 2001; 121 966-969
59 Sax H C, Souba W W. Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am. 1993; 77 863-880
60 ASPEN Board of Directors, Clinical Guidelines Task Force . Indications for specialized nutrition support. JPEN. 2002; 26 18SA-20SA
61 Brennan M F, Ekman L. Metabolic consequences of nutritional support of the cancer patient. Cancer. 1984; 54 2627-2634
62 Bodoky A, Dupont V, Heberer M, Harder F. Heimenterale Ernährung über Jejunostomiekatheter. Helvetica Chirurgica Acta. 1990; 57 141-146
63 Campos A C, Butters M, Meguid M M. Home enteral nutrition via gastrostomy in advanced head and neck cancer patients. Head & Neck. 1990; 12 137-142
64 Klein S, Koretz R L. Nutrition support in patients with cancer: What do the data really show?. Nutr Clin Pract. 1994; 9 91-100
65 Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice. Supp Care Cancer. 1998; 6 85-93
66 Evans W K, Nixon D W, Daly J M. et al . A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol. 1987; 5 113-124
67 Ovesen L, Allingstrup L. Different quantities of two commercial liquid diets consumed by weigh-losing cancer patients. JPEN. 1992; 16 275-278
68 Lee J H, Machtay M, Unger L D. et al . Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998; 124 871-875
69 Bozzetti F, Cozzaglio L, Gavazzi C. et al . Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori. 1998; 84 681-686
70 Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res. 1991; 121 269-282
71 Ottery F D, Walsh D, Strawford A. Pharmacologic management of anorexia/cachexia. Sem Oncol. 1998; 25 35-44
72 Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (Review). Anticaner Res. 1997; 17 657-662
73 McMillan D C, O'Gorman P, Fearon K CH, McArdle C S. A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. Br J Cancer. 1997; 76 788-790
74 Simons J PFHA, Schols A M, Hoefnagels J MJ, Westerterp K R, tenVelde G PM, Wouters E F. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer. Cancer. 1998; 82 553-560
75 Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive Behandlung mit Megestrolacetat während der Radio-(Chemo-)Therapie bei Patienten mit Tumoren im Kopf-Hals-Bereich. Strahlentherapie und Onkologie. 1996; 172 162-168
76 Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald R N. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer. 1990; 66 1279-1282
77 McMillan D C, Simpson J M, Preston T. et al . Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. Clin Nutr. 1994; 13 85-89
78 Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol. 2001; 12 289-300
79 Loprinzi C L, Kugler J W, Sloan J A. et al . Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol. 1999; 17 3299-3306
80 Wigmore S J, Ross J A, Falconer J S. et al . The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996; 12 27-30
81 Barber M D, Ross J A, Voss A C, Tisdale M J, Fearon K CH. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999; 81 80-86
82 Wigmore S J, Barber M D, Ross J A, Tisdale M J, Fearon K CH. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000; 36 177-184
83 Gogos C A, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos N C, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer. 1998; 82 395-402
84 Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, DiCarlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002; 122 1763-1770
85 van Bokhorst-de van de Schueren M AE, Quak J J, von Blomberg-van der Flier M E. et al . Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr. 2001; 73 323-332
86 Daly J M, Weintraub F N, Shou J, Rosato E F, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995; 221 327-338
87 Thiel H J, Fietkau R, Sauer R. Malnutrition and the role of nutritional support for radiation therapy patients. Recent Results Cancer Res. 1988; 108 205-226
88 Collins M M, Wight R G, Partridge G. Nutritional consequences of radiotherapy in early laryngeal carcinoma. Ann Royal Coll Surg. 1999; 81 376-381
89 Arnold C, Richter M P. The effect of oral nutritional supplements on head and neck cancer. Int J Radiat Oncol Biol Phys. 1989; 16 1595-1599
90 Nayel H, el-Ghoneimy E, el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumours treated with irradiation. Nutrition. 1992; 8 13-18
91 Marcy P Y, Magné N, Bensadoun R J. et al . Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Supp Care Cancer. 2000; 8 410-413
92 Tyldesley S, Sheehan F, Munk P. et al . The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys. 1996; 36 1205-1209
93 Öhrn K EO, Wahlin Y B, Sjöden P O. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Supp Care Cancer. 2001; 9 247-257
94 Mekhail T M, Adelstein D J, Rybicki L A, Larto M A, Saxton J P, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Cancer. 2001; 91 1785-1790
95 Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care. 1997; 6 45-49
96 Roberge C, Tran M, Massoud C. et al . Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer. Br J Cancer. 2000; 82 263-269
97 Weisdorf S A, Lysne J, Wind D. et al . Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987; 43 833-838
98 Herrmann V M, Petruska P J. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract. 1993; 8 19-27
99 Szeluga D J, Stuart R K, Brookmeyer R, Utermohlen V, Santos G W. Nutritional support of bone marrow transplant recipients: a prospective, randomised clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res. 1987; 47 3309-3316
100 Roberts S R, Miller J E. Success using PEG tubes in marrow transplant recipients. Nutr Clin Pract. 1998; 13 74-78
101 Anderson P M, Ramsay N K, Shu X O. et al . Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998; 22 339-344
102 Schloerb P R, Skikne B S. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN. 1999; 23 117-122
103 Coghlin-Dickson T M, Wong R M, Offrin R S. et al . Effect of oral glutamine supplementation during bone marrow transplantation. JPEN. 2000; 24 61-66
104 Bozzetti F. Is enteral nutrition a primary therapy in cancer patients?. Gut. 1994; 35 S65-S68
105 Rabeneck L, McCullough L B, Wray N P. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet. 1997; 349 496-498
106 Löser C, Müller M J. Ethische Richtlinien zur Anlage einer perkutan endoskopischen Gastrostomie (PEG-Sonde). Zschr Gastroenterol. 1998; 36 475-478
107 Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. JPEN. 1989; 13 406-420
108 Sartori S, Trevisani L, Tassinari D. et al . Cost analysis of long-term feeding by percutaneous endoscopic gastrostomy in cancer patients in an Italian health district. Supp Care Cancer. 1996; 4 21-26
109 Lindh A, Cedermark B, Blomgren H, Wassermann J, Petrini B. Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer. J Surg Oncol. 1986; 33 61-65

Dr. med. Jann Arends

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg

Breisacher Straße 117

79106 Freiburg

eMail: arends@tumorbio.uni-freiburg.de